Ideas
Favor export-driven Korean consumer names.
Lee expects the February correction to be short-lived and favors export-driven Korean consumer names with solid earnings. Cosmetics and food/beverage are highlighted because overseas demand, especially amid Korea-Japan-China tensions, supports revenue growth and earnings resilience.
Buy laggard pharma with strong earnings.
Within Korean pharma/biotech, previously hot obesity, ADC and platform names led the market. Now laggards with strong earnings and foreign/institutional accumulation are attractive as earnings season approaches.
Watch HBM4 share shift.
Samsung's first HBM4 mass production headline is less important than actual volume and Micron's alleged zero share. If Micron's zero share is real, Samsung and SK hynix benefit, but the stock reaction did not differentiate. Watch Micron's U.S. trading as confirmation.
KOSDAQ policy favors quality large caps.
The government's KOSDAQ activation plan will not lift every stock. Lee favors KOSDAQ 150 and top-cap, earnings-based growth companies in semiconductor materials, pharma/biotech, robotics, batteries, and token-securities/STO beneficiaries.
AmorePacific earnings recovery supports upside.
AmorePacific lost the cosmetics market-cap crown to APR, but remains a strong, large competitor. Earnings and margins are improving with exports and a bottom recovery, making the stock attractive.
Dalba Global bottoming on export growth.
Dalba Global is recovering from the bottom on strong export and earnings momentum. The prior quarter miss was due to marketing costs, not structural weakness, and Q4 results are a catalyst.
Buy HD Hyundai Electric on patience.
HD Hyundai Electric's report showed near-perfect fundamentals. Despite conservative guidance limiting target hikes, 2028-29 earnings can support a 1.1 million KRW target. Buy below 900,000 KRW and wait two to three months.
Securities benefit from higher trading volume.
KOSDAQ activation and a KOSPI breakout would increase trading volume and deposits, making securities stocks one of the most elastic beneficiaries.
Follow Hanwha Solutions momentum.
Hanwha Solutions illustrates how analyst capitulation, target upgrades, and volume expansion can create follow-on momentum. When target prices are raised and volume persists, traders can follow the move.
Intelliantech momentum still has room.
Intelliantech hit limit-up after a report raised the target sharply. Institutional buying and the space/defense narrative support momentum while opinions are still divided and liquidity remains ample.
Celltrion breakout on earnings recovery.
Celltrion has been accumulated by foreigners and institutions for months. Earnings are improving, merger synergies are expected, and it is breaking a long trading range as it exceeds past operating and net profit peaks.
Wait for Alteogen trend reversal.
Alteogen's long-term platform story remains attractive, but the trend broke after bad news and margin growth may slow. New entry should wait for a trend reversal, while holders can manage exposure.
Buy Sam Chun Dang on pullback.
Sam Chun Dang Pharmaceutical is high-risk and high-difficulty, but earnings momentum and margins are improving sharply. Lee suggests buying on a February correction or rest and expects a new high.
Prefer Hyundai E&C over Doosan.
In the nuclear theme, a fresh catalyst matters. Hyundai E&C's construction angle is newer than Doosan Enerbility's already-known equipment story, so Hyundai E&C should outperform.
Prefer Hyundai E&C over Doosan.
In the nuclear theme, a fresh catalyst matters. Hyundai E&C's construction angle is newer than Doosan Enerbility's already-known equipment story, so Hyundai E&C should outperform.
Medical beauty benefits from obesity drugs.
Obesity treatments are accelerating the lifting and aesthetic procedures market. Medical-beauty names combining pharma/biotech momentum and earnings, such as PharmaResearch, Hugel, Classys, and LNC Bio, are attractive especially on market corrections.
Hold Samsung Electro-Mechanics for 2027.
MLCC, BGA, and FC-BGA data from Japan and Taiwan remain very strong. Samsung Electro-Mechanics is attractive, but has only limited upside to the 350,000-360,000 KRW target, so holders can wait until 2027 numbers are clearer.
Avoid legacy software, prefer platforms.
AI agents are disrupting legacy software business models. Old, comfortable software firms may struggle, while outcome and platform companies like Palantir are relatively better positioned.
Avoid legacy software, prefer platforms.
AI agents are disrupting legacy software business models. Old, comfortable software firms may struggle, while outcome and platform companies like Palantir are relatively better positioned.
Korean memory remains in sweet spot.
AI capex is unprecedented, memory supply shortages may last to 2028, and HBM remains the bottleneck. Samsung and SK hynix dominate HBM4 while Micron's share is falling, keeping Korean memory in a sweet spot.
Buy Korean shipbuilding defense nuclear.
Korean shipbuilding, defense, and nuclear offer 20-30% earnings growth to 2030 with high predictability from MRO and defense demand, contributing roughly 40% of index upside.
Watch AI infrastructure funding stress.
Hyperscaler AI capex is exceeding internally generated cash flow, forcing debt and equity funding. Watch Oracle CDS, Amazon, Blue Owl, and Apollo for signs of financing stress that could hit financials.
Rotate to U.S. value sectors.
U.S. market leadership is broadening from growth and M7 toward value, staples, healthcare, and energy as investors rotate into cash-flow-generating, value-style stocks.
Increase Korean equity allocation.
Mok argues investors should increase Korean equity weight because the Korea discount is resolving through value-up, commercial law revision, mandatory treasury-share cancellation, and foreign inflows, while Korea offers AI supply-chain exposure.
Raise gold and commodities exposure.
Mok recommends raising commodity exposure, especially gold, citing Asian central-bank demand and the debasement trade. Global banks see gold above $6,000.
Use 25/25/25/25 four-season portfolio.
An equal-weight four-season portfolio of 25% equities, 25% bonds, 25% gold, and 25% cash has historically been powerful and beat 60/40, with gold hedging inflation and cash protecting in recessions.
Hold 10-20% cash for risk.
Lee remains positive on the Korean market but, after a sharp rally and with 3-4% daily volatility, recommends holding 10-20% cash for risk management.
Prefer U.S. financials and Dow.
If trading U.S. stocks, Lee prefers financials and Dow-related value names over M7 and growth because the growth-value gap is narrowing and value rotation is underway.
Buy Korean financials and KB.
Korean financials should follow the U.S. value rotation, and domestic policy and value-up reforms with high shareholder returns support banks and securities. KB Financial has shown strong price action.
Buy Samsung and SK hynix.
Lee favors Samsung Electronics and SK hynix within KOSPI: memory shortages may last through 2027, capex and ASPs are rising, Micron is investing more in LAND while Korean firms lead in HBM ROI, and valuations remain low with potential MSCI developed-market re-rating.
Prefer KOSPI over KOSDAQ.
Lee prefers KOSPI over KOSDAQ because KOSPI is led by semiconductors and liquidity, while KOSDAQ is more volatile and dependent on policy execution.
Prefer KOSPI over KOSDAQ.
Lee prefers KOSPI over KOSDAQ because KOSPI is led by semiconductors and liquidity, while KOSDAQ is more volatile and dependent on policy execution.
Power equipment sector is broadening.
Power equipment, solar, and nuclear are the next narratives after semiconductors. Sanil Electric, the weakest fundamental among major power-equipment names, rose 11-12%, a bullish sign for the whole power-equipment group.
Korean solar benefits from reshoring.
Trump and Musk-driven anti-China supply-chain reshoring benefits Korean solar. Hanwha Solutions, HD Hyundai Energy Solutions, OCI Holdings, Shinsung E&G, and SDN are moving on this theme.
AmorePacific earnings improving, but hot.
Hyundai Motor Securities raised AmorePacific's target to 170,000 KRW on EPS upgrade. China sales fell but operating profit turned positive via store restructuring, while U.S./Europe and new brands like Cosrx grow. Fundamentals are positive but the stock is short-term overheated.
Sanil Electric discount should narrow.
Sanil Electric posted record Q4 operating profit, data center and renewables sales more than doubled, order backlog is strong, and its valuation discount to large power-equipment peers should narrow. The report target is 180,000 KRW.
Daehan Wire narrative, weak margins.
Daehan Electric Wire's target was raised to 35,000 KRW on rising high-voltage submarine cable sales and copper-price benefits, but very low operating margin, low ROE, and high P/E leave it vulnerable to volatility.
GS E&C earnings growth ahead.
GS E&C is expected to show high 2026 earnings growth as housing margins improve and additional settlement gains arrive. Order backlog and new housing plans support profitability even as revenue shrinks.
ISC benefits from AI test sockets.
ISC beat consensus with Q4 sales up 84% and 30% operating margin on non-memory test socket orders and hyperscaler volume. ASIC customer expansion and mass-production share gains support a 200,000 KRW target.
This 3PRO TV (삼프로TV) video, published February 09, 2026,
features Lee Chang, Kim Jang-yeol, Mok Dae-gyun, Lee Jae-kyu, Cha Young-joo
discussing KORU, Korean food & beverage sector, Korean pharma/biotech laggards, 005930.KS, 000660.KS, MU, KOSDAQ 150, 090430.KS, 483650.KS, 267260.KS, Korean securities sector, 009830.KS, 189300.KQ, 068270.KS, 196170.KQ, 000250.KQ, 000720.KS, 034020.KS, 214450.KQ, 145020.KQ, Classys, 290650.KQ, 009150.KS, Legacy software/SaaS, PLTR, Korean shipbuilding/defense/nuclear, ORCL, AMZN, OWL, APO, XLV, XLE, XLP, EWY, DBC, Equities, GLD, CASH, DJI, XLF, 105560.KS, Korean financials sector, KOSDAQ, 062040.KS, Korean Power Equipment Sector, HD Hyundai Energy Solutions, 010060.KS, 011930.KS, 260870.KQ, 001440.KS, 006360.KS, 095340.KQ.
39 trade ideas extracted by AI with direction and confidence scoring.
Speakers:
Lee Chang,
Kim Jang-yeol,
Mok Dae-gyun,
Lee Jae-kyu,
Cha Young-joo
· Tickers:
KORU,
Korean food & beverage sector,
Korean pharma/biotech laggards,
005930.KS,
000660.KS,
MU,
KOSDAQ 150,
090430.KS,
483650.KS,
267260.KS,
Korean securities sector,
009830.KS,
189300.KQ,
068270.KS,
196170.KQ,
000250.KQ,
000720.KS,
034020.KS,
214450.KQ,
145020.KQ,
Classys,
290650.KQ,
009150.KS,
Legacy software/SaaS,
PLTR,
Korean shipbuilding/defense/nuclear,
ORCL,
AMZN,
OWL,
APO,
XLV,
XLE,
XLP,
EWY,
DBC,
Equities,
GLD,
CASH,
DJI,
XLF,
105560.KS,
Korean financials sector,
KOSDAQ,
062040.KS,
Korean Power Equipment Sector,
HD Hyundai Energy Solutions,
010060.KS,
011930.KS,
260870.KQ,
001440.KS,
006360.KS,
095340.KQ
